Levomer

Levofloxacin, the active ingredient in Levomer, is a fluoroquinolone presented as an ophthalmic preparation for ocular use. It is employed to treat bacterial eye infections caused by susceptible organisms in adult and pediatric patients. The drug is formulated for topical administration directly onto the eye surface, delivering high local concentrations while minimizing systemic exposure.

GNH USA supplies Levomer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, ophthalmology centres and clinics worldwide.

Levofloxacin is a fluoroquinolone antibacterial used in ophthalmology to treat bacterial infections of the eye. - Bacterial conjunctivitis: reduces bacterial load and speeds resolution of redness, discharge and irritation. - Bacterial keratitis: eradicates causative pathogens, promoting corneal healing and visual recovery. - Blepharitis: diminishes bacterial colonisation of eyelid margins, alleviating inflammation and crusting. - Post‑operative prophylaxis: prevents infection after ocular surgery such as cataract extraction.

Levofloxacin eye drops may cause local and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Stinging or foreign‑body feeling. - Conjunctival hyperemia (redness). - Transient blurred vision. - Mild tearing. - Eyelid edema.

Serious or Rare Side Effects: - Allergic reactions such as severe eyelid swelling, rash or anaphylaxis. - Corneal ulceration or perforation. - Tendon rupture or tendonitis (systemic exposure). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Vision loss due to intra‑ocular inflammation.

Before prescribing Levomer, consider the following safety measures. - Allergy assessment: avoid in patients with known fluoroquinolone hypersensitivity. - Corneal integrity: use with caution on compromised corneal epithelium. - Concurrent corticosteroids: monitor closely for delayed wound healing or perforation. - Systemic exposure: advise patients to report tendon pain or swelling. - Store at room temperature: keep in the original container, protect from moisture and light.

Levofloxacin ocular formulation can interact with other systemic or ophthalmic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase overall fluoroquinolone exposure. - Topical corticosteroids: may heighten risk of corneal thinning or perforation.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: could affect corneal healing. - Other ophthalmic antibiotics: may reduce combined efficacy. - Warfarin: systemic absorption could potentiate anticoagulation; monitor INR if long‑term use is anticipated.